Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

This study tests a new treatment for a type of bile duct cancer that cannot be removed by surgery. About 42 adults will receive a combination of a drug called durvalumab (which helps the immune system fight cancer) and a procedure that uses heat to destroy cancer cells inside the…

This study tests whether a daily pill called ivosidenib can help prevent bile duct cancer from returning in people who have already had surgery and chemotherapy. The drug targets a specific genetic change (IDH1 mutation) found in some bile duct cancers. About 40 adults with this …

This study is observing how lung cancer patients fare when treated with the immunotherapy drug Tislelizumab in everyday clinics, not just in controlled trials. Researchers will track survival, treatment patterns, side effects, and quality of life in 240 participants across German…

This study is a large registry that collects information from up to 9,000 people in Germany with sarcoma (a rare type of cancer). Researchers will track what treatments patients receive and how they do over time. The goal is to better understand the disease and improve future car…